Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

9478	Companies
185482	Keywords
117825	Articles
99322	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

BRIEF

published on 11/06/2025 at 20:00, 28 days 19 hours ago

Pentixapharm Holding AG Reduces Projected Loss for 2025

Biotech Industry Clinical Development Cost Reduction Financial Forecast Strategic Optimization
PRESS RELEASE

published on 11/06/2025 at 19:55, 28 days 19 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm significantly reduces projected loss for financial year 2025
Pentixapharm Holding AG significantly reduces projected loss for financial year 2025 due to clinical development program realignment

Clinical Development Realignment Pentixapharm Financial Year 2025 Projected Loss
BRIEF

published on 10/23/2025 at 22:17, 1 month 12 days ago

Pentixapharm recentre sa stratégie et réduit ses coûts

Développement Clinique Réduction Des Coûts Produits Radiopharmaceutiques Réduction Des Effectifs Stratégie Biotechnologique
BRIEF

published on 10/23/2025 at 22:17, 1 month 12 days ago

Pentixapharm Refocuses Strategy and Reduces Costs

Clinical Development Cost Reduction Radiopharmaceuticals Workforce Reduction Biotech Strategy
PRESS RELEASE

published on 10/23/2025 at 22:12, 1 month 12 days ago

Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure
Pentixapharm strengthens pipeline prioritization, reduces early-stage research activities, and cuts costs by 50%. Focus on Phase 3-ready program for treatment-resistant hypertension diagnosis

Clinical Development Cost Reduction Pentixapharm Pipeline Prioritization Diagnosis Program
BRIEF

published on 10/23/2025 at 21:04, 1 month 12 days ago

Pentixapharm Shifts Focus to Clinical Advancement and Strengthens Finances

Financial Strategy Radiopharmaceuticals Clinical Programs Workforce Reduction Pentixapharm
BRIEF

published on 10/23/2025 at 21:04, 1 month 12 days ago

Pentixapharm se concentre sur le développement clinique et renforce ses finances

Stratégie Financière Produits Radiopharmaceutiques Programmes Cliniques Réduction Des Effectifs Pentixapharm
PRESS RELEASE

published on 10/23/2025 at 20:59, 1 month 12 days ago

EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm Focuses Development on Advanced Clinical Programs and Strengthens Financial Position by Discontinuing Preclinical Activities
Pentixapharm Holding AG strengthens financial position by focusing on advanced clinical programs and discontinuing preclinical activities, reducing costs and extending cash runway

Financial Position Cost Reduction Clinical Programs Pentixapharm Preclinical Activities
BRIEF

published on 10/06/2025 at 11:05, 1 month 30 days ago

Pentixapharm dévoile des données prometteuses sur le radiopharmaceutique CXCR4 à l'EANM 2025

Traitement Du Cancer De La Vessie CXCR4 Radiopharmaceutiques Diagnostic De L'aldostéronisme Primaire Conférence EANM 2025 Innovations Pentixapharm
BRIEF

published on 10/06/2025 at 11:05, 1 month 30 days ago

Pentixapharm Unveils Promising CXCR4 Radiopharmaceutical Data at EANM 2025

Bladder Cancer Treatment CXCR4 Radiopharmaceuticals Primary Aldosteronism Diagnostics EANM 2025 Conference Pentixapharm Innovations

Accesswire

Published on 12/05/2025 at 15:25, 7 minutes ago

Usha Resources Provides Corporate Updates
Published on 12/05/2025 at 15:00, 32 minutes ago

Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 14:00, 1 hour 32 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 32 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 57 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 15:05, 27 minutes ago

Seegene Establishes French Subsidiary to Expand European Footprint
Published on 12/05/2025 at 14:22, 1 hour 10 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 1 hour 16 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 1 hour 22 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 47 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings

Les Echos

Published on 12/05/2025 at 15:10, 22 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 22 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 1 hour 34 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 47 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 47 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE